Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at SAR 780.8B, ahead of Johnson & Johnson (SAR 747.2B) and Sanofi (SAR 527.7B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSAR 780.8B
- Median
- SAR 13.2B
- Combined market value
- SAR 19.23T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SAR 780.8B | SAR 605.4B | SAR 106.21 | 0.54% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SAR 747.2B | SAR 2.5T | SAR 1,039.25 | 0.59% down | 38% up | ||
| 3 | SanofiSNY · Health Care | SAR 527.7B | SAR 428.2B | SAR 178.32 | 0.02% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SAR 513.4B | SAR 1.3T | SAR 527.35 | 1.94% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | SAR 502.5B | SAR 1.93T | SAR 1,089.33 | 0.84% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | SAR 427.9B | SAR 1.05T | SAR 676.79 | 0.98% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | SAR 421.9B | SAR 4.71T | SAR 5,291.57 | 0.34% down | 35% up | ||
| 8 | NovartisNVS · Health Care | SAR 416.2B | SAR 1.11T | SAR 589.88 | 1.18% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | SAR 364.4B | SAR 257.8B | SAR 80.68 | 0.62% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SAR 337.7B | SAR 464.9B | SAR 227.42 | 1.22% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SAR 325.3B | SAR 680.6B | SAR 392.95 | 0.00% | 17% down | ||
| 12 | GSKGSK · Health Care | SAR 304.3B | SAR 370.1B | SAR 184.66 | 0.02% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | SAR 302.2B | SAR 663.3B | SAR 150.49 | 1.43% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 152.8B | SAR 187.3B | SAR 160.49 | 0.41% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SAR 152.1B | SAR 373.1B | SAR 3,606.32 | 0.38% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | SAR 139.5B | SAR 88.2B | SAR 76.96 | 0.32% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SAR 96.2B | SAR 510.4B | SAR 2,013.14 | 0.47% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | SAR 82B | SAR 22.1B | SAR 32.45 | 0.23% up | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SAR 73.6B | SAR 147.9B | SAR 257.21 | 0.16% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | SAR 58B | SAR 128.5B | SAR 316.21 | 0.98% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | SAR 50.1B | SAR 49B | SAR 97.94 | 1.01% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | SAR 48.3B | SAR 119.6B | SAR 193.93 | 0.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 43.7B | SAR 58B | SAR 903.33 | 0.05% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | SAR 30.7B | SAR 174.3B | SAR 1,525.83 | 1.57% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | SAR 29.6B | SAR 92.8B | SAR 2,178.13 | 0.59% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SAR 28.5B | SAR 42.6B | SAR 220.18 | 0.32% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 23.1B | SAR 46.8B | SAR 56.11 | 1.15% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | SAR 21.4B | SAR 104.9B | SAR 144.79 | 0.28% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | SAR 18.6B | SAR 77.7B | SAR 579.75 | 1.24% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SAR 13.8B | SAR 27.7B | SAR 79.45 | 0.28% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | SAR 13.2B | SAR 16.9B | SAR 101.57 | 0.43% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | SAR 10.9B | SAR 18.8B | SAR 225.17 | 0.55% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | SAR 9.3B | SAR 29.1B | SAR 173.26 | 1.63% up | 58% up | ||
| 34 | InsmedINSM · Health Care | SAR 8.5B | SAR 99.8B | SAR 454.70 | 0.53% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | SAR 6.5B | SAR 12B | SAR 61.95 | 2.52% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | SAR 5.9B | SAR 22B | SAR 1,101.71 | 0.03% down | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | SAR 5.4B | SAR 65.9B | SAR 1,004.29 | 1.27% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | SAR 5.3B | SAR 27.1B | SAR 194.64 | 0.46% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 5.2B | SAR 22.7B | SAR 160.79 | 0.29% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 4.7B | SAR 36.2B | SAR 1,559.19 | 1.50% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | SAR 4B | SAR 35.6B | SAR 235.45 | 0.10% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | SAR 3.5B | SAR 32B | SAR 1,143.21 | 0.09% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | SAR 3.5B | SAR 18.4B | SAR 105.97 | 1.44% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | SAR 3.5B | SAR 55.9B | SAR 287.08 | 0.35% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | SAR 3.2B | SAR 22.5B | SAR 345.04 | 0.04% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | SAR 3.1B | SAR 28.5B | SAR 260.08 | 1.05% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | SAR 2.9B | SAR 24.2B | SAR 596.41 | 0.81% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | SAR 2.9B | SAR 33.7B | SAR 354.51 | 0.75% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 2.9B | SAR 28.5B | SAR 362.87 | 1.71% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | SAR 2.8B | SAR 32.2B | SAR 40.25 | 0.56% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | SAR 2.6B | SAR 26.5B | SAR 503.61 | 1.24% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | SAR 2.5B | SAR 30.4B | SAR 465.54 | 0.45% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | SAR 2.4B | SAR 27.4B | SAR 312.93 | 1.61% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | SAR 2.3B | SAR 18.1B | SAR 188.79 | 1.51% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | SAR 2.1B | SAR 16.8B | SAR 153.90 | 2.40% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | SAR 2B | SAR 18.3B | SAR 324.93 | 0.41% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | SAR 1.8B | SAR 24.8B | SAR 365.38 | 1.13% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 1.8B | SAR 29.9B | SAR 431.03 | 1.46% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | SAR 1.7B | SAR 15B | SAR 109.75 | 0.41% down | 169% up | ||
| 60 | ErascaERAS · Health Care | SAR 1.5B | SAR 17.7B | SAR 50.34 | 3.38% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | SAR 572.5M | SAR 20B | SAR 474.69 | 0.72% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (SAR 780.8B), Johnson & Johnson (SAR 747.2B) and Sanofi (SAR 527.7B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of SAR 19.23T as of 18 Nov 2026, 14:51 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.